EGFR and neoplasm: Moreover, HIF-2α (but not HIF-1α) has been shown to cooperate with a number of oncoproteins frequently deregulated in cancer, such as c-Myc, epidermal growth factor receptor, and K-Ras and promoted tumor aggressiveness, EMT and invasion [4, 24].